News and Trends 16 Mar 2023
Mediar Therapeutics boosts fibrosis portfolio with $105M financing
Mediar Therapeutics Inc., a biotechnology company advancing a portfolio of first-in-class therapies that halt and even reverse the course of fibrosis, has announced a $105 million financing. This includes a…